GSM Foils Ltd — Q4 FY26 earnings call

Call held 22 Apr 2026

Management summary

GSM Foils Limited delivered strong financial performance in Q4 and FY26, driven by robust revenue growth and improved PAT margins. The Ahmedabad plant is ramping up well, contributing to capacity expansion. However, the company faced near-term cost pressures from volatile commodity prices and high receivables in March, which were largely mitigated by April. Management highlighted working capital management and client relationships as key competitive advantages and plans for future forward integration.

Highlights

  • Q4 FY26 Revenue grew robustly by 79.1% YoY to ₹81.69 crores.

  • FY26 Revenue saw strong growth of 92.9% YoY, reaching ₹258.15 crores.

  • FY26 EBITDA increased significantly by 95.9% YoY to ₹29.78 crores.

  • FY26 PAT margin expanded by 50 bps to 7.7%, reflecting sustained operational efficiency.

  • Ahmedabad manufacturing facility is ramping up well and is expected to reach optimal utilization by FY27 end.

Concerns

  • Q4 FY26 EBITDA margin moderated by 120 bps to 11.5% from 12.7% in Q4 FY25.

  • Near-term cost pressure persists due to high commodity prices (aluminium, petrochemicals) and global supply chain disruptions.

  • Receivables became high in March 2026 due to pharma companies' funds being stuck, though largely recovered in April.

Key financials

2 periods

Headline

  • Revenue
    ₹81.689 Cr
    YoY +79.1%
  • EBITDA
    ₹9.43 Cr
    YoY +62.5%
  • EBITDA Margin
    11.5%
  • PAT
    ₹6.279 Cr
    YoY +83.6%
  • PAT Margin
    7.7%

FY26

  • Revenue
    ₹258.154 Cr
    YoY +92.9%
  • EBITDA
    ₹29.783 Cr
    YoY +95.9%
  • PAT Margin
    7.7%

What they filed

Q1 FY27: revenue up 86.3%, net profit up 99.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue31 36 46 52 58 +86%66 +84%82 +79%97 +86%
EBITDA3 4 6 6 7 +107%8 +95%9 +63%12 +98%
Net profit2 3 3 4 4 +107%5 +96%6 +84%8 +99%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Capital allocation

high confidence
  • Capex Capex disclosed
    • Ahmedabad manufacturing facility ₹5 Cr
    Okay, okay. Fair enough. And like you were explaining, like I think our Ahmedabad capex was around INR5 crores to INR6 crores and from that only I think in the first step we will be able to recover all our cost of capital.
  • Debt Debt disclosed
    • New borrowing Debt facility from ICICI Bank ₹15 Cr
    And on top of that, we got a debt facility from ICICI Bank of around INR15 crores during that phase.
  • Liquidity Liquidity disclosed Cash flow was managed well with new funds coming in, enabling procurement despite high rates. Good inventory levels maintained.
    So, cash flow was managed well with this new funds coming in now, so we were able to procure more from the purchase part to because the rate was going almost around 8% to 10% plus in this month which eventually went, the aluminium prices went up by around INR50, which is equivalent to 10%.

Guidance & targets

Capacity

  • Ahmedabad plant optimal utilization Capacity · FY27 end · High confidence Optimal utilization
    Going ahead, we remain focused on further scaling of this facility and aim to achieve an optimal utilization level at the end of next financial year, thereby enhancing overall operational efficiency and supporting future growth.

    — Sagar Bhanushali

Revenue

  • Ahmedabad plant monthly revenue potential Revenue · per month (at optimal capacity) · High confidence INR 30 crores to INR 35 crores
    If you look at an average basis price then on an average, on a monthly basis I can comment you once it reaches optimal capacity, on a monthly run rate it would give me around INR30 crores to INR35 crores per month.

    — Sagar Bhanushali

  • Vasai plant additional monthly revenue Revenue · per month · High confidence INR 6 crores to INR 7 crores
    And with few here and there spares and addition, we can increase it up to 20%, so more around INR6 to INR7 crores revenue can be pulled from the Vasai plant.

    — Sagar Bhanushali

  • Total monthly run rate Revenue · by March '27 · High confidence INR 60 crores
    That is the plan, yes. That is the vision that we are taking forward currently.

    — Sagar Bhanushali

  • FY27 Topline Revenue · FY27 · High confidence INR 400 crores to INR 450 crores
    But on a very realistic and like what do I say, even if we do a very like mediocre or average business in this year now, then also our topline for the entire year would be around INR400 crores to INR450 crores, sir.

    — Sagar Bhanushali

Margin

  • EBITDA Margin Margin · FY27 · Medium confidence 11.5%
    If you are asking any commitment, then definitely we will try to sustain the current level if not increase, but sustenance at current level is then definitely be looked at.

    — Sagar Bhanushali

  • Forward integration margin Margin · post implementation · Medium confidence 8-10%
    After this, lower end even if you catch it becomes 8 to 10%.

    — Sagar Bhanushali

Capex

  • Forward integration capex announcement Capex · in a quarter or two · Medium confidence Announcement
    With like a quarter or two we may come up with a very good announcement of capex also, but currently things are under plan.

    — Sagar Bhanushali

  • Forward integration implementation Capex · 6 months to a year / end of FY27 · Medium confidence Implementation
    So maybe six months to a year. Maybe sometime towards the end of FY27 we can expect.

    — Sagar Bhanushali

What to watch in Q1 FY27

Ahmedabad Plant Utilization Progress

next quarter
Current 25-30%
Target Increased utilization towards optimal by FY27 end

Why it matters

Tracking the ramp-up of the Ahmedabad plant is crucial for achieving the targeted FY27 revenue and capacity goals.

We have reached almost 25% to 30% over there. ... Going ahead, we remain focused on further scaling of this facility and aim to achieve an optimal utilization level at the end of next financial year

Risks & concerns

  • Commodity price volatility (aluminium, petrochemicals)

    medium

    Aluminium LME and MCX at all-time high, petrochemicals also expensive, leading to near-term cost pressure.

    Management acknowledged

  • Working capital management challenges

    medium

    Receivables can be delayed by 120-150 days in the pharma sector, requiring careful management and sufficient liquidity.

    Management acknowledged

  • Global market uncertainty

    medium

    Ongoing global conflicts (Iran, Israel, US) create market volatility and uncertainty, making aggressive expansion difficult.

    Management acknowledged

Q&A highlights

6 direct, 1 evasive
Ahmedabad Plant Utilization and Revenue Potential Direct
We have reached almost 25% to 30% over there. ... on a monthly run rate it would give me around INR30 crores to INR35 crores per month.

Clarifies the current operational status and future revenue contribution from the new Ahmedabad facility, a key growth driver.

Asked by Deepak Poddar

Overall Monthly Revenue Target Direct
That is the plan, yes. That is the vision that we are taking forward currently.

Establishes a clear, quantified target for the company's combined monthly revenue run rate by March '27, indicating significant growth ambition.

Asked by Deepak Poddar

Commodity Price Volatility and Margin Sustainability Partial
The rate increase like every day, aluminium LME and even the MCX is almost on an all-time high. ... eventually it was passed on. But let's see how far this it goes and it has to settle over the period of time, but I don't know how long would it take for the situation to normalize now.

Highlights the ongoing challenge of raw material price volatility and the uncertainty around its impact on future margins, despite current ability to pass on costs.

Asked by Deepak Poddar

High Receivables and Working Capital Management Direct
During the month of March specifically, majority of the pharma companies, their funds got stuck because of few LCs or export payment or dollar payment because all these conflicts going on, the rates and all. So they had a special request from us if you can manage this thing now. ... Normally it is 60 to 70 days.

Explains the reason for elevated receivables in Q4, confirms subsequent recovery, and reiterates the importance of working capital management as a core competitive strength.

Asked by Deepak Poddar

Employee Cost Discrepancy Evasive
No, sir. But last year Q4 I see our employee cost almost INR10.8 crores, but this year only INR6.9 crores something? ... Then give me some time, sir and definitely I have to look at that.

An analyst identified a significant year-on-year decline in employee costs for Q4 FY26, which management could not immediately explain, warranting further clarification.

Asked by Subhanu Bangal

Competitive Advantages and Sustainable Growth Direct
The only competitive edge that we have is that volume that we are doing. So we are more cost effective compared to our competitors. Secondly, with more funds of this rights issue and bank ODs, we are able to provide more credit to our clients.

Management articulated its core competitive advantages, focusing on scale, cost-effectiveness, and the ability to provide credit, which are crucial in the pharma packaging sector.

Asked by Abhi Jain

Future Capex Plans and Forward Integration Direct
definitely we are planning, sir. We won't be stuck at this level also. With like a quarter or two we may come up with a very good announcement of capex also, but currently things are under plan. That's what I will tell you. ... We are looking at forward integration only, sir.

Indicates the company's intent for future capacity expansion beyond current plans, specifically targeting forward integration, which could enhance margins and market position.

Asked by Darshil Jhaveri

Order Visibility and Contract Structure Direct
That's what I told you there is no such contract or orders or that thing. The PO comes in every month. POs normally executed within two to three days. It doesn't take time in conversion. So there is no specific contract or order visibility, but we were quite confident with the set of customers that we have.

Clarifies the company's operational model, which relies on short-term purchase orders rather than long-term contracts, impacting how 'order book' is traditionally understood for capital goods companies.

Asked by Atharva Kulkarni

3 min read 6 chapters

Detailed narrative

Strong Financial Performance in Q4 and FY26

GSM Foils Limited reported robust financial results for Q4 FY26, with revenue reaching ₹81.69 crores, a significant 79.1% year-on-year increase. PAT for the quarter grew by 83.6% YoY to ₹6.28 crores, with PAT margin improving by 20 basis points to 7.7%. For the full fiscal year FY26, the company achieved a revenue of ₹258.15 crores, marking a strong 92.9% YoY growth, and EBITDA stood at ₹29.78 crores, up 95.9% YoY. The FY26 PAT margin expanded by 50 basis points to 7.7%, underscoring sustained operational efficiency and scale benefits.

Ahmedabad Plant Expansion and Future Capacity

The Ahmedabad manufacturing facility is ramping up well, currently operating at 25-30% utilization. Management aims to achieve optimal utilization by the end of FY27. At optimal capacity, this plant is expected to generate ₹30-35 crores in revenue per month. Combined with the Vasai plant, which currently generates ₹25-28 crores per month and has potential for an additional ₹6-7 crores, the company targets a total monthly run rate of ₹60 crores by March 2027. This expansion is crucial for supporting growth and catering to an expanding customer base in western and northern regions.

Impact of Global Supply Chain Disruptions and Commodity Prices

Global conflicts, particularly involving Iran, Israel, and the US, have significantly impacted the global supply chain, leading to a tremendous increase in prices for metals like aluminium and petrochemical derivatives used in pharmaceutical packaging. While GSM Foils faced some pressure in March due to these rising costs, they were eventually passed on to customers. Management noted that the situation's normalization timeline remains uncertain, but the company's ability to pass on costs helps sustain margins, with a target to maintain current EBITDA levels around 11.5% for FY27.

Working Capital Management and Receivables

The company experienced high receivables in March 2026, primarily due to funds being stuck with pharma companies facing issues with LCs and export payments. However, a significant portion (₹30-40 crores) was recovered in early April. Management emphasized that efficient working capital management, including maintaining a 60-70 day receivables cycle in the pharma sector, is a key competitive advantage. The recent ₹15 crore debt facility from ICICI Bank also helped manage cash flow and maintain good inventory levels during this period.

Strategic Focus on Forward Integration and Market Expansion

GSM Foils' growth strategy continues to focus on diversification and strong operational execution. While the immediate focus is on ramping up the Ahmedabad plant and serving existing clients, the company is planning for future capex towards forward integration. This will involve setting up specialized printing or conversion units for pharmaceutical packaging, which could potentially double current margins. An announcement regarding these capex plans is expected within a quarter or two, with implementation possibly by the end of FY27.

Competitive Advantages and Risk Management

Management highlighted that their competitive edge lies in their volume, which makes them more cost-effective, and their strong working capital management capabilities. By leveraging funds from rights issues and bank ODs, they can offer necessary credit to clients, a critical factor in the pharma industry where payments can be delayed up to 120-150 days. The primary risk identified is the inability to manage working capital effectively, as money doesn't sink but can come late. The company maintains conservative credit checks, especially for new clients in Ahmedabad, to mitigate this risk.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Capital Goods earnings calls